Search Results - Matthew J. Bott

Refine Results
  1. 1
    Pericardial effusions in the cancer population: Prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability

    Pericardial effusions in the cancer population: Prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability by Patrick Wagner, Eileen McAleer, Elizabeth E. Stillwell, Matthew J. Bott, Valerie W. Rusch, Wendy Schaffer, James Huang

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy

    Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy by Marie Brevet, Shigeki Shimizu, Matthew J. Bott, Neerav Shukla, Qin Zhou, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations

    Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations by Marjorie G. Zauderer, Matthew J. Bott, Robert McMillan, Camelia S. Sima, Valerie W. Rusch, Lee M. Krug, Marc Ladanyi

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

    New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment by Marc Ladanyi, Marjorie G. Zauderer, Lee M. Krug, Tatsuo Ito, Robert McMillan, Matthew J. Bott, Filippo G. Giancotti

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Management and Outcomes of Relapse After Treatment for Thymoma and Thymic Carcinoma

    Management and Outcomes of Relapse After Treatment for Thymoma and Thymic Carcinoma by Matthew J. Bott, Hanghang Wang, William D. Travis, Gregory J. Riely, Manjit S. Bains, Robert J. Downey, Valerie W. Rusch, James Huang

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?

    Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors? by Matthew J. Bott, Aalok Patel, Traves D. Crabtree, Graham A. Colditz, Daniel Kreisel, Alexander S. Krupnick, G. Alexander Patterson, Stephen Broderick, Bryan F. Meyers, Varun Puri

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis

    Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis by Takashi Eguchi, Koji Kameda, Shaohua Lu, Matthew J. Bott, Kay See Tan, Joseph Montecalvo, Jason C. Chang, Natasha Rekhtman, David R. Jones, William D. Travis, Prasad S. Adusumilli

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy

    Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy by Inderpal S. Sarkaria, Nabil P. Rizk, Debra A. Goldman, Camelia S. Sima, Kay See Tan, Manjit S. Bains, Prasad S. Adusumilli, Daniela Molena, Matthew J. Bott, Thomas M. Atkinson, David R. Jones, Valerie W. Rusch

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non–small cell lung cancer

    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non–small cell lung cancer by M. Jawad Latif, Kay See Tan, Daniela Molena, James Huang, Matthew J. Bott, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch, Manjit S. Bains, Robert J. Downey, David R. Jones, James M. Isbell

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors

    Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors by Matthew J. Bott, Jonathan Cools‐Lartigue, Kay See Tan, Joseph Dycoco, Manjit S. Bains, Robert J. Downey, James Huang, James M. Isbell, Daniela Molena, Bernard J. Park, Valerie W. Rusch, Smita Sihag, David R. Jones, Prasad S. Adusumilli

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions

    Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions by Or Kalchiem‐Dekel, James G. Connolly, I‐Hsin Lin, Bryan Husta, Prasad S. Adusumilli, Jason Beattie, Darren J. Buonocore, Joseph Dycoco, Paige Fuentes, David R. Jones, Robert P. Lee, Bernard J. Park, Gaetano Rocco, Mohit Chawla, Matthew J. Bott

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma

    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma by Arianna Barbetta, Meier Hsu, Kay See Tan, Dessislava Stefanova, Koby Herman, Prasad S. Adusumilli, Manjit S. Bains, Matthew J. Bott, James M. Isbell, Yelena Y. Janjigian, Geoffrey Y. Ku, Bernard J. Park, Abraham J. Wu, David R. Jones, Daniela Molena

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma by Matthew J. Bott, Marie Brevet, Barry S. Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard Lake, Maureen F. Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon N. Powell, Qin Zhou, Ronglai Shen, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer by Matthew J. Bott, Stephen C. Yang, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch, James M. Isbell, Robert J. Downey, Julie R. Brahmer, Richard J. Battafarano, Errol L. Bush, Jamie E. Chaft, Patrick M. Forde, David R. Jones, Stephen Broderick

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma

    Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma by Neel P. Chudgar, Murray F. Brennan, Rodrigo Ramella Munhoz, Peter R. Bucciarelli, Kay See Tan, Sandra P. D’Angelo, Manjit S. Bains, Matthew J. Bott, James Huang, Bernard J. Park, Valerie W. Rusch, Prasad S. Adusumilli, William D. Tap, Samuel Singer, David R. Jones

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma by Raul Caso, Francisco Sánchez-Vega, Kay See Tan, Brooke Mastrogiacomo, Jian Zhou, Gregory D. Jones, Bastien Nguyen, Nikolaus Schultz, James G. Connolly, Whitney S. Brandt, Matthew J. Bott, Gaetano Rocco, Daniela Molena, James M. Isbell, Yuan Liu, Marty W. Mayo, Prasad S. Adusumilli, William D. Travis, David R. Jones

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma

    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma by James G. Connolly, Kay See Tan, Brooke Mastrogiacomo, Joseph Dycoco, Raul Caso, Gregory D. Jones, Patrick J. McCormick, Francisco Sánchez-Vega, Takeshi Irie, Joseph R. Scarpa, Hersh Gupta, Prasad S. Adusumilli, Gaetano Rocco, James M. Isbell, Matthew J. Bott, Gregory W. Fischer, David R. Jones, Joshua S. Mincer

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach

    Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Appro... by Jason C. Chang, Deepu Alex, Matthew J. Bott, Kay See Tan, Venkatraman Seshan, Andrew Golden, Jennifer L. Sauter, Darren J. Buonocore, Chad Vanderbilt, Sounak Gupta, Patrice Desmeules, Francis M. Bodd, Gregory J. Riely, Valerie W. Rusch, David R. Jones, Maria E. Arcila, William D. Travis, Marc Ladanyi, Natasha Rekhtman

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination

    NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination by Marcus Ruscetti, Josef Leibold, Matthew J. Bott, Myles Fennell, Amanda Kulick, Nelson R. Salgado, Chi-Chao Chen, Yu-Jui Ho, Francisco J. Sánchez‐Rivera, Judith Feucht, Timour Baslan, Sha Tian, Hsuan-An Chen, Paul B. Romesser, John T. Poirier, Charles M. Rudin, Elisa de Stanchina, Eusebio Manchado, Charles J. Sherr, Scott W. Lowe

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer

    Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer by Adam J. Schoenfeld, Hira Rizvi, Danish Memon, Narek Shaverdian, Matthew J. Bott, Jennifer L. Sauter, C. Jillian Tsai, Jayon Lihm, David Hoyos, Andrew J. Plodkowski, Rocío Pérez-Johnston, Peter Sawan, Jacklynn V. Egger, Benjamin D. Greenbaum, Andreas Rimner, Gregory J. Riely, Charles M. Rudin, Valerie W. Rusch, Daniel R. Gomez, Matthew D. Hellmann

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: